ARK Invest Discloses 20.6M Share Stake in Recursion Pharma

TL;DR

**ARK Invest just revealed a huge stake in Recursion Pharma, signaling big institutional confidence.**

AI Summary

ARK Investment Management LLC, a prominent investment firm, reported on January 29, 2024, that as of December 31, 2023, they beneficially own 20,654,287 shares of Recursion Pharmaceuticals, Inc. Class A Common Stock. This represents a significant stake, giving ARK substantial influence over the company's future direction. For current or prospective shareholders, this indicates a major institutional investor's strong belief in Recursion's long-term potential, potentially signaling stability or future growth, but also means ARK's future trading decisions could heavily impact the stock price.

Why It Matters

This filing reveals a major institutional investor's significant ownership in Recursion Pharmaceuticals, which can influence market perception and the stock's liquidity.

Risk Assessment

Risk Level: medium — While a large institutional holder can provide stability, their future selling activity could also create downward pressure on the stock.

Analyst Insight

A smart investor would monitor ARK Investment Management LLC's future filings (e.g., 13F reports) to track any changes in their Recursion Pharmaceuticals holdings, as significant selling could signal a shift in their investment thesis.

Key Numbers

• 20,654,287 — Shares Beneficially Owned (Total shares of Recursion Pharmaceuticals, Inc. Class A Common Stock held by ARK Investment Management LLC as of December 31, 2023.)
• 19,867,781 — Sole Voting Power Shares (Shares over which ARK Investment Management LLC has exclusive voting control.)
• 469,164 — Shared Voting Power Shares (Shares over which ARK Investment Management LLC shares voting control with others.)

Key Players & Entities

• ARK Investment Management LLC (company) — the reporting person and institutional investor
• Recursion Pharmaceuticals, Inc. (company) — the subject company whose stock is being reported
• Delaware (person) — place of organization for ARK Investment Management LLC
• December 31, 2023 (dollar_amount) — date of event which requires filing
• January 29, 2024 (dollar_amount) — filing date

Forward-Looking Statements

• ARK Investment Management LLC will maintain a significant stake in Recursion Pharmaceuticals, Inc. for the foreseeable future. (ARK Investment Management LLC) — medium confidence, target: Q4 2024

FAQ

Filing Documents

• tm244117d2_sc13g.htm (SC 13G) — 48KB
• 0001104659-24-007690.txt ( ) — 50KB

(a) Name of issuer

Item 1(a) Name of issuer: Recursion Pharmaceuticals, Inc.

(b) Address of issuer's principal executive offices

Item 1(b) Address of issuer's principal executive offices: 41 S Rio Grande Street Salt Lake City, UT 84101

(a) Name of person filing

Item 2(a) Name of person filing: ARK Investment Management LLC

(b) Address or principal business office or, if none,

Item 2(b) Address or principal business office or, if none, residence: ARK Investment Management LLC 200 Central Avenue St. Petersburg, FL 33701

(c) Citizenship

Item 2(c) Citizenship: Delaware, United States

(d) Title of class of securities

Item 2(d) Title of class of securities: Common Stock

(e) CUSIP No

Item 2(e) CUSIP No.: 75629V104

If this statement is filed pursuant to §§ 240.13d-1(b) or

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 75629V104 13G Page 4 of 5 Pages

Ownership

Item 4. Ownership (a) Amount beneficially owned: 20,654,287 (b) Percent of class: 9.92% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 19,867,781 (ii) Shared power to vote or to direct the vote: 469,164 (iii) Sole power to dispose or to direct the disposition of: 20,654,287 (iv) Shared power to dispose or to direct the disposition of: 0

Ownership

Item 5. Ownership of 5 Percent or Less of a Class. Not applicable.

Ownership of More than 5 Percent on Behalf of Another Person

Item 6. Ownership of More than 5 Percent on Behalf of Another Person. To the knowledge of the Reporting Person, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the shares which represents more than five percent of the number of outstanding class of the shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 75629V104 13G Page 5 of 5 Pages

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The reporting persons agree that this statement is filed on behalf of each of them. Dated: January 29, 2024 ARK Investment Management LLC By: /s/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer

View Full Filing

View this SC 13G filing on SEC EDGAR